Pharmacogenomics instruction in US and Canadian medical schools: Implications for personalized medicine

Pharmacogenomics

Volumn 11, Issue 9, 2010, Pages 1331-1340

  Green, James S ^a,b   Obrien, Travis J ^b   Chiappinelli, Vincent A ^b   Harralson, Arthur F ^a,b  

^a SHENANDOAH UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

curriculum; medical school; personalized medicine; pharmacogenomics education; physician education

Indexed keywords

ARTICLE; BIOMEDICINE; CANADA; CLINICAL COMPETENCE; CURRICULUM DEVELOPMENT; EDUCATION PROGRAM; HEALTH CARE SURVEY; HUMAN; MEDICAL EDUCATION; MEDICAL SCHOOL; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PHYSICIAN; UNITED STATES;

ACCREDITATION; CANADA; CURRICULUM; EDUCATION, MEDICAL; GREAT BRITAIN; HUMANS; INDIVIDUALIZED MEDICINE; OSTEOPATHIC MEDICINE; PHARMACOGENETICS; SCHOOLS, MEDICAL; SCHOOLS, PHARMACY; TEACHING; UNITED STATES;

EID: 77957172283     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.10.122     Document Type: Article

References (16)

1. Weinshilboum R: Inheritance and drug response. N. Engl. J. Med. 348(6), 529-537 (2003).
2. Hampton T: Researchers draft guidelines for clinical use of pharmacogenomics. JAMA 296(12), 1453-1454 (2006).
3. Evans JP: Health care in the age of genetic medicine. JAMA 298(22), 2670-2672 (2007).
4. Frueh FW, Gurwitz D: From pharmacogenetics to personalized medicine, a vital need for educating health professionals and the community. Pharmacogenomics 5(5), 571-579 (2004).
5. Gurwitz D, Weizman A, Rehavi M: Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends Pharmacol. Sci. 24(3), 122-125 (2003).
6. Gurwitz D, Lunshof JE, Dedoussis G et al.: Pharmacogenomics education: International Society of Pharmacogenomics recommendations for medical, pharmaceutical, and health schools deans of education. Pharmacogenomics J. 5, 221-225 (2005).
7. Frueh FW, Goodsaid F, Rudman A, Huang S-M, Lesko LJ: The need for education in pharmacogenomics: a regulatory perspective. Pharmacogenomics J. 5, 218-220 (2005).
8. Glickman SW, McHutchison JG, Peterson ED et al.: Ethical and scientifc implications of the globalization of clinical research. N. Engl. J. Med. 360(8), 816-823 (2009).
9. Latif DA, McKay AB: Pharmacogenetics and pharmacogenomics instruction in colleges and schools of pharmacy in the United States. Am. J. Pharm. Educ. 69(2), 152-156 (2005).
10. Murphy JE, Green JS, Adams LA, Squire RB, Kuo GM, McKay AB: Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am. J. Pharm. Educ. 74(1), 1-10 (2010).
11. Thurston VC, Wales PS, Bell MA, Torbeck L, Brokaw JJ: The current status of medical genetics instruction in U.S. and Canadian medical schools. Acad. Med. 82(5), 441-445 (2007).
12. Higgs JE, Andrews J, Gurwitz D, Payne K, Newman W: Pharmacogenetics education in British medical schools. Genomic Med. 2, 101-105 (2008).
13. Dienstag JL: Relevance and rigor in premedical education. N. Engl. J. Med. 359(3), 221-224 (2008).
14. Churchill GA, Iacobucci D: Marketing Research: Methodological Foundations (9th Edition). South-Western Publishers, MA, USA (2005).
15. Carey L: Pharmacogenetics: what PAs need to understand and why. JAAPA 22(7), 61-62 (2009).
16. Beery TA, Hern MJ: Genetic practice, education, and research. Clin. Nurse Spec. 18(3), 126-132 (2004).